Is the NHS ready for the biosimilars boom? to most, biosimilars are a no-brainer. But as with anything new, there are early adopters and sceptics. The NIHR CRN is an independent, government-funded organization which supports delivery of the majority of clinical research in England - and with that comes unique insight.
